Capricor Therapeutics' GAAP loss for 2021 was $20.023 million, up 46.6% from $13.657 million the previous year. Revenue was down 21.1% to $244,898,000 from $310,25,000 a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept